Abstract Introduction: Prior to the 2017 Philadelphia Consensus Conference guidelines,
genetic testing for prostate cancer was conducted based on personal and family history of …

234 Background: Prior to the guidelines set forth by the 2017 Philadelphia consensus
conference, genetic testing for prostate cancer was conducted based on personal and family …

Purpose: Genetic testing may alter clinical management for individuals with metastatic
prostate cancer by identifying additional therapies. Traditional counseling models are …

METHODS The Canadian Genitourinary Research Consortium (GURC) administered a
cross-sectional survey to a largely academic, multidisciplinary group of investigators across …

Background Multiple studies have confirmed a high prevalence of prognostic germline
mutations in prostate cancer. In recognition, the NCCN guidelines and recommendations for …

Germline genetic testing is now routinely recommended for patients with prostate cancer
(PCa) because of expanded guidelines and options for targeted treatments. However …

Background Prostate cancer (PCA) germline testing (GT) is now standard-of-care for men
with advanced PCA. Thousands of men may consider GT due to clinical and family history …

Introduction The 2018 National Comprehensive Cancer Network guidelines for prostate
cancer genetic testing expanded access to genetic services. Few studies have examined …

PURPOSE Germline testing (GT) is a central feature of prostate cancer (PCA) treatment,
management, and hereditary cancer assessment. Critical needs include optimized …

Germline testing for inherited prostate cancer is revolutionizing prostate cancer treatment for
advanced and metastatic disease and is beginning to inform management for early-stage …